The pharmaceutical sector in India experienced a downturn on March 23, 2026, as reflected in early morning trading data from BSE and NSE around 9:29-9:30 AM IST. Most listed pharma stocks showed declines, aligning with broader market weakness.
Market Context
- The S&P BSE Sensex stood at 73,240.13, down 1.73%.
- The Nifty 50 was at 22,704.40, down 1.77%.
- This indicates a general market decline, with pharma stocks participating in the sell-off.
Pharma Stocks Performance (Early March 23, 2026)
Nearly all major pharma scrips traded lower on BSE and NSE:
- Aarti Drugs: BSE 339.00 (-1.28%), NSE 338.60 (-1.33%)
- Abbott India: BSE 26,219.00 (-1.92%), NSE 26,200.00 (-1.93%)
- Ajanta Pharma: BSE 2,848.60 (-1.91%), NSE 2,850.90 (-1.85%)
- Alembic Pharma: BSE 662.15 (-2.20%), NSE 662.10 (-2.24%)
- Alkem Laboratories: BSE 5,192.00 (-1.25%), NSE 5,181.50 (-1.45%)
- Aurobindo Pharma: BSE 1,283.60 (-0.60%), NSE 1,282.30 (-0.70%)
- Biocon: BSE 374.95 (-1.56%), NSE 374.85 (-1.60%)
- Cipla: BSE 1,245.85 (-0.80%), NSE 1,245.00 (-0.91%)
- Divis Laboratories: BSE 6,017.40 (-1.39%), NSE 6,019.00 (-1.33%)
- Dr. Reddy’s Lab: BSE 1,281.00 (-1.38%), NSE 1,279.40 (-1.50%)
- Glenmark Pharma: BSE 2,138.90 (-1.93%), NSE 2,136.90 (-1.98%)
- Ipca Labs: BSE 1,519.30 (-1.79%), NSE 1,516.80 (-1.82%)
- Laurus Labs: BSE 974.00 (-1.29%), NSE 974.40 (-1.30%)
- Lupin: BSE 2,303.00 (-0.84%), NSE 2,305.10 (-0.75%)
- Mankind Pharma: BSE 1,969.50 (-1.51%), NSE 1,967.10 (-1.64%)
- Sun Pharma: BSE 1,766.60 (-0.61%), NSE 1,766.80 (-0.58%)
- Torrent Pharma: BSE 4,220.30 (-1.11%), NSE 4,221.00 (-1.15%)
- Zydus Lifesciences: BSE 884.00 (-0.74%), NSE 884.20 (-0.71%)
Exceptions included minor gains or flat performance in a few stocks like Indoco Remedies (BSE +1.22%) and Kwality Pharma (+0.74% on BSE), but the sector trend was predominantly negative.
Also read: Metal sector stocks decline sharply today, March 23: Hindustan Zinc falls 5%, Vedanta down 4.49%, NALCO drops 4.18%